http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008129656-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
filingDate 2006-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2008129656-A
titleOfInvention SUBSTITUTED PYRAZINONE DERIVATIVES AS AN ALPHA-2C-ADRENORECEPTOR ANTAGONISTS
abstract 1. The compound of General formula (I)! ! its pharmaceutically acceptable acid or base addition salt, its stereochemically isomeric form, its N-oxide form or its quaternary ammonium salt, where! V represents a naphthyl radical, wherein one CH unit in the naphthyl moiety may optionally be substituted with an N atom; ! Y is a divalent radical of formula (II)! ! where a represents a nitrogen atom or carbon; ! m is an integer equal to zero, 1 or 2; ! R4 is selected from the group consisting of hydrogen, alkyl, and phenylcarboxylalkyl; ! R5 is selected from the group consisting of hydrogen and halogen; ! X1, X2 are each, independently of one another, a covalent bond, a saturated or unsaturated (C1-8) -hydrocarbon radical in which one or more divalent -CH2 units and / or one or more monovalent CH3 units may optionally be replaced by the corresponding divalent or monovalent phenyl units and in which one or more hydrogen atoms can be replaced by radicals selected from the group consisting of oxo, (C1-3) alkyloxy; halogen, cyano, nitro, formyl, hydroxy, amino, trifluoromethyl, mono- and di ((C1-3) alkyl) amino, carboxy and thio; ! p, q are, each independently from each other, an integer equal to 1 or 2; ! Q1, Q2 are, each independently of one another, a radical selected from the group consisting of hydrogen, —NR1R2, Pir, —OR3 and Het, where two —OR3 radicals can be taken together to form the divalent radical —O— (CH2 ) rO-, where r is an integer equal to 1, 2 or 3; ! R1 and R2 are, each independently of one another, a radical selected from
priorityDate 2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457489092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456414897
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID488793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457626896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457651511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457461622
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546850
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID428799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457793265
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457629203
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457492341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457795386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457633337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455585947
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415806325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456485498
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24175
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID266752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457802656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421355313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457520418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456636799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101175

Total number of triples: 68.